High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024. In the quarter to July 2026, revenue grew 30.7%, EPS grew 800.0%, free cash flow fell 7.91% and total debt rose 54.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow HITI
High Tide Inc. (HITI) EV/Sales
As of 16 October 2026, High Tide Inc. (HITI) trades at a EV/Sales of 0.5×. Over the past ten years it has ranged from 0.0× (July 2020) to 59.7× (February 2021); the current reading is higher than 48% of that period. That is below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | 16.18% |
| FY2024 | 0.6× | 60.13% |
| FY2023 | 0.4× | (14.85%) |
| FY2022 | 0.4× | (76.71%) |
| FY2021 | 1.9× | 89.09% |
| FY2020 | 1.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jul 2026 | 0.4× | (16.25%) |
| Apr 2026 | 0.5× | 1.89% |
| Jan 2026 | 0.5× | (23.89%) |
| Oct 2025 | 0.7× | 53.12% |
| 24 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDVLQ MedAvail Holdings, Inc. compare | −0.3× |
| BIMI BIMI Holdings Inc. compare | −0.1× |
| RDGT Ridgetech Inc. compare | 0.0× |
| POM Pomdoctor Limited - Sponsored ADR compare | n/m |
| PETS PetMed Express, Inc. compare | 0.1× |
| HITI High Tide Inc. | 0.5× |
| MEDS DataMeds AI, Inc compare | 3.0× |
| SCNX Scienture Holdings, Inc. compare | 162× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)